Injections: A Practical Comparison For patients weighing both options, some real-world differences matter beyond the clinical trial results
, ,
(Link) An Op-Ed from Kat McDavitt and Lisa Bari We need a Chief Patient Officer in the US Department of Health and Human Services The Forgotten Man of mRNA Research by the Wall Street Journals (paywall) Gregory Zuckerman If you enjoyed this post, subscribe to Hospitalogy, my newsletter breaking down the finance, strategy, innovation, and M&A of healthcare
caution is also warranted with anticoagulants, oral contraceptives, and other GLP-1 receptor agonists
A 2025 preprint study analyzing over 3,000 patients found that women on semaglutide had more than twice the risk of hair loss compared to women on an alternative weight loss medication, while the signal in men was not statistically significant
The International journal of neuroscience , 37 1-2, 85-8